Published in J Biol Chem on August 03, 2015
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
The RXR heterodimers and orphan receptors. Cell (1995) 12.33
A decade of molecular biology of retinoic acid receptors. FASEB J (1996) 9.70
Gene expression regulation by retinoic acid. J Lipid Res (2002) 3.62
Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene (2004) 3.41
Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci (2007) 3.20
Overview of retinoid metabolism and function. J Neurobiol (2006) 3.19
Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci U S A (1991) 2.85
The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci (2009) 2.80
Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing (1992) 2.12
Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol (2007) 1.90
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc Natl Acad Sci U S A (2006) 1.81
Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription. Proc Natl Acad Sci U S A (2009) 1.76
Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease. Prog Neurobiol (2006) 1.75
Quantification of endogenous retinoic acid in limited biological samples by LC/MS/MS. Biochem J (2005) 1.73
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci (2006) 1.68
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation (2008) 1.59
Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A (2001) 1.53
Role of retinoid signalling in the adult brain. Prog Neurobiol (2005) 1.47
High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem (2008) 1.41
Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci (1999) 1.38
IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. J Biol Chem (2000) 1.36
Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J Neurosci Res (2007) 1.30
Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci (2008) 1.30
Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J (2009) 1.28
Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci (2004) 1.25
Vitamin A deficiency produces spatial learning and memory impairment in rats. Neuroscience (2002) 1.24
Evidence for defective retinoid transport and function in late onset Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 1.23
Retinoic acid-gated sequence-specific translational control by RARalpha. Proc Natl Acad Sci U S A (2008) 1.22
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation. Neurobiol Aging (2010) 1.21
Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling. J Neurosci (2001) 1.20
NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J Biol Chem (2008) 1.19
Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. J Cell Physiol (2006) 1.18
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. Int J Neuropsychopharmacol (2011) 1.15
Chromatographic analysis of endogenous retinoids in tissues and serum. Anal Biochem (2003) 1.14
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells. Genes Dev (2003) 1.13
Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. Behav Brain Res (2003) 1.13
Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol (2002) 1.11
Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin Immunol (2006) 1.09
Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol Neurodegener (2011) 1.06
Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. Histol Histopathol (2006) 1.02
Leptin attenuates BACE1 expression and amyloid-β genesis via the activation of SIRT1 signaling pathway. Biochim Biophys Acta (2014) 1.00
Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons. Cell Metab (2013) 0.98
Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages. J Leukoc Biol (1994) 0.96
Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J Nutr Biochem (2008) 0.95
Towards retinoid therapy for Alzheimer's disease. Curr Alzheimer Res (2009) 0.92
Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory. Front Neurosci (2014) 0.92
Retinoid receptors and therapeutic applications of RAR/RXR modulators. Curr Top Med Chem (2012) 0.91
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev Neurother (2009) 0.90
Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J (2004) 0.88
Age-related decreases in mRNA for brain nuclear receptors and target genes are reversed by retinoic acid treatment. Neurosci Lett (1997) 0.87
Vitamin A and Alzheimer's disease. Geriatr Gerontol Int (2011) 0.86
Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J Immunol (1994) 0.85
TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease. Neurobiol Aging (2007) 0.84
Regulation of secretases by all-trans-retinoic acid. FEBS J (2009) 0.83
Is the modulation of retinoid and retinoid-associated signaling a future therapeutic strategy in neurological trauma and neurodegeneration? J Neurochem (2007) 0.83
All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules. Cell Adh Migr (2010) 0.83
Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease. Eur J Neurol (1999) 0.82
Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes. J Neurochem (2008) 0.81
Intracranial injection of LPS in rat as animal model of neuroinflammation. Methods Mol Biol (2013) 0.81
All-trans retinoic acid attenuates experimental colitis through inhibition of NF-κB signaling. Immunol Lett (2014) 0.80
All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation. Arthritis Res Ther (2008) 0.79
Retinoids for treatment of Alzheimer's disease. Biofactors (2012) 0.78